Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Sorafenib in Advanced HCC
NCT00044512Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2002
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Bayer. Started Aug 2002; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00044512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044512.